China SXT Pharmaceuticals, Inc. is a wholly foreign-owned enterprise established by China SXT Group (Hong Kong) Limited through its subsidiary, Jiangsu SXT Pharmaceutical Co., Ltd. (former “Taizhou Renji Traditional Chinese Medicine Pieces Co., Ltd” found in June, 2005”) located in Taizhou City, Jiangsu Province of P. R. China. The subsidiary company is a pharmaceutical GMP-certified (containing the scope on manufacturing directly oral) traditional Chinese medicine (TCM) company mainly with broad expertise in research, development, manufacturing, marketing, and sales of advanced traditional Chinese medicine pieces (the “TCMP”) (directly oral and after-soaking-oral TCMP), as well as fine and regular TCMP products. Our advanced TCMP products are being distributed rapidly to GSP-certified commercial Pharmaceutical companies, hospitals, and drugstores nationwide.
Dr. Jingzhen, Deng, a veteran in TCM industry, joined the company in June, 2013 and rebuilt our research and development (R & D) team. Dr. Deng has almost 20 years of experiences at university and pharmaceutical companies specializing in natural products in the USA and more than 14 years at university and institute in TCM in China. He established our general R & D strategy utilizing new technology and approaches to revolutionize TCMP production , and continue developing newly advanced and non-decocting TCMP/TCM products capable of meeting the highest quality standard. Our advanced TCMP products comply with the regulations of Chinese Food and Drug Administration (CFDA) or provincial FDA, and corresponding standards of China pharmacopoeia (version 2015) , as well as keep to the all of principles of Chinese Traditional Medicine. Our R & D demonstrated that the directly-oral and after-soaking oral products, in contrast to regular TCMPs, are in the possession of significant advantages in non-decocting, keeping TCM original ingredients, improving bioavailability of bioactive constitutes, easy storage, saving crude materials, and more safety.
On the 14th China Scientist Forum held on September, 2017 in Beijing, China, our company was granted three awards in regard to the research and development of advanced TCMP products, (directly-oral and after-soaking-oral TCMP): Innovation Award, Achievement Award, and 1th outstanding R & D Article Award, which supports strongly that our research and development are in pioneering and leading status in the aspect nationwide.
We own centuries-old brand “Suxuantang”（the ”SXT”）. Our brand-“SXT”TCMP products were granted the award of Jiangsu Taizhou Famous Product in December 2016. Nowadays, we have committed to build a new production base very soon in Taizhou covering 34,000 square meters, including facilities for advanced TCMP, fine and regular TCMP, and traditional Chinese patent medicine (TCPM) production, storage center, R&D center, marketing center, and other associated facilities. We believe that with the recognizing-brand “SXT”, R & D innovation capability, and sale-network-building potentials, our company can be a top-ranking enterprise in manufacturing, and sales for advanced TCMP, TCPM in the future.